Evaluation of the relationship between serum G protein-coupled estrogen receptors (GPER-1) levels and the severity and duration of the disease in patients with androgenetic alopecia: A case-control study
- 5 October 2024
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (9) , 1-7
Abstract
There are studies revealing the effects of estrogen receptors alpha (α) and beta (β) on hair follicles. However, the effects of G protein-coupled estrogen receptors (GPER-1) on hair follicles have not been elucidated. This study aims to evaluate the relationship between serum GPER-1 levels and the severity and duration of the disease in patients with androgenetic alopecia (AGA). The study included 81 patients with AGA aged 18 to 50 years (22 men and 19 women with an onset of AGA more than 5 years, and 20 men and 20 women with an onset of AGA less than 5 years) and 40 healthy controls (20 men, 20 women). The mean age of participants with AGA was 29.12 ± 8.15 (18-50), and the mean age of the control group was 25.21± 4.71 (19-42). Serum GPER-1 levels were measured, and the relationship between GPER-1 levels and duration of the disease, severity of the disease, and sex was statistically evaluated. The serum level of GPER-1 was significantly higher in patients with AGA as compared to the control group (p < 0.001). A negative correlation was found between serum GPER-1 levels and the duration of the disease in both men and women (p < 0.001, r = 0.793; p < 0.001, r = 0.711, respectively). There was a significant relationship between serum GPER-1 levels and the severity of the disease in both men and women (p = 0.003; p = 0.002, respectively). Additionally, a significant difference in GPER-1 levels was noted between male and female patients with AGA (p = 0.001). However, no statistically significant relationship was identified between GPER-1 levels and estrogen levels (p = 0.097). The higher levels of GPER-1 in patients with AGA compared to the control group, and the significant relationship between GPER-1 levels and both the duration and severity of the disease, suggest an estrogen-independent role of GPER-1 in the pathogenesis of AGA. The fact that GPER-1 levels are high in the early stages of AGA when inflammation is prominent suggests that treatments targeting these receptors may be effective at this stage.Keywords
Funding Information
- Kahramanmaras Sutcu Imam University Scientific Research Project Unit (2022/2-15 M, 2022/2-15 M, 2022/2-15 M, 2022/2-15 M)
This publication has 40 references indexed in Scilit:
- Icariin attenuates vascular endothelial dysfunction by inhibiting inflammation through GPER/Sirt1/HMGB1 signaling pathway in type 1 diabetic ratsChinese Journal of Natural Medicines, 2024
- The G protein-coupled oestrogen receptor GPER in health and disease: an updateNature Reviews Endocrinology, 2023
- Evaluation of serum G protein-coupled estrogen receptor 1 (GPER-1) levels in patients with androgenetic alopeciaArchives of Dermatological Research, 2021
- Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopeciaBiomedicine & Pharmacotherapy, 2021
- Pattern hair loss: Assessment of inflammation and fibrosis on histologic sectionsJournal of the American Academy of Dermatology, 2020
- GPER blockers as Nox downregulators: A new drug class to target chronic non-communicable diseasesThe Journal of Steroid Biochemistry and Molecular Biology, 2018
- G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosisCancer Letters, 2016
- The Estrogen Receptors: An Overview from Different Perspectives2016
- Vasodilatory effects of the selective GPER agonist G-1 is maximal in arteries of postmenopausal womenMaturitas, 2014
- The comparative histopathology of male-pattern baldness and senescent baldnessClinics in Dermatology, 1988